Conatus Pharmaceuticals Inc. (CNAT)

[micham2012]

I get that.

But I gather from the discussion on this Board that the top line results are "highly anticipated" because of earlier tests and that no one can tell anything about the trial to be reported. This is the part I find hard to accept. It seems an odd time for a road show. Frankly, I am cynical enough to believe that those in charge of the trial have a sense of how it has gone, but then again, I know next to nothing about the protocols and mechanics of double blind studies.

There is a sense in which this trifecta of dog and pony shows -- building excitement, when presumably you have nothing new to say -- has an air of manipulation about it.

Maybe I do not truly appreciate the likelihood that the results are good or the significance of Novartis support. I ask the question because I am very, very long this stock, and felt a bit blind-sided by the public offering 10 months ago.